GENOMIC DESIGN BIOENGINEERING COMPANY has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in Republic of Korea, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, agriculture and measurement are BIOPSYTEC GMBH, TOVSS and SNPSHOT TRUSTEE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 7 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Agriculture | |
#3 | Measurement | |
#4 | Pharmaceuticals | |
#5 | Biotechnology | |
#6 | IT methods for management | |
#7 | Chemical engineering | |
#8 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Animal care | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Microorganisms | |
#6 | Separation | |
#7 | Microbiology | |
#8 | Water treatment | |
#9 | Data processing systems |
# | Name | Total Patents |
---|---|---|
#1 | Ryu Jae Ho | 10 |
#2 | Park Hae Chul | 8 |
#3 | Yeo Sang Yeob | 7 |
#4 | Cheol Hee Kim | 1 |
#5 | Song In Su | 1 |
#6 | Jae Ho Ryu | 1 |
#7 | Hae Chul Park | 1 |
#8 | Kim Cheol Hee | 1 |
#9 | Jung Seung Hyun | 1 |
#10 | Sang Yeob Yeo | 1 |
Publication | Filing date | Title |
---|---|---|
KR101849051B1 | Apparatus for culturing rotifer | |
KR101721192B1 | Apparatus for fish breeding | |
KR101443738B1 | Screening methods for acetylcholine related bioactive materials using inherited color preference of fish | |
WO2014014189A1 | Device and method for screening for bioactive materials using visual recognition of animals | |
KR20140003983A | The device for screening physiological active substances by using visual recognition of animal and the method for the same | |
KR20100138252A | Zebrafish mbp promoter capable of directing myelin-specific expression, generation of transgenic animal having mbp promoter, and its use as a disease model for multiple sclerosis |